Clinical Trial Update: HAART 200 Aortic Valve Annuloplasty Trial [NA]

View source ↗

Summary

The HAART 200 Aortic Valve Annuloplasty trial sponsored by Biostable Science & Engineering has completed for aortic insufficiency, with results posted in March …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Insufficiency

Snippet

Sponsor: Biostable Science & Engineering | Conditions: Aortic Insufficiency | NA | Status: COMPLETED | Results posted: 2017-03-20